NanoTox™ assures strategic advantages by early safety and risk assessment of nanoproducts.
nanoTox™ identifies rapidly, cost-effectively and confidentially potential safety/health risks in any stage of the product lifecycle. nanoTox™ studies biological, physical and environmental properties to create maximum understanding of the nanoproducts, beyond the purpose it was designed for and supports the responsible development and usage of nanotechnologies.
With locations in Austin TX and Maastricht, The Netherlands, nanoTox™ complies with US and European toxicology standards and access to multiple research capabilities to improve our stage-wise, tier-based, decision tree approach.
Understanding product safety creates a competitive advantage, better due diligence and limited liability to the manufacturer